What countries have banned Sunosi (solriamfetol)?
I don’t have enough provided information to identify specific countries where Sunosi has been banned. Sunosi is a prescription medicine (solriamfetol), and “banned” can also mean different things in different places, such as a full market withdrawal, a regulatory prohibition, or restrictions on prescribing.
Is Sunosi banned, withdrawn, or restricted somewhere?
Even when a drug is described as “banned” online, regulators often impose one of these instead:
- A marketing ban or authorization refusal (the product never enters that market)
- A withdrawal from the market
- Tighter prescribing limits (e.g., only for specific indications or patient groups)
- Safety-driven label changes rather than a full ban
To answer accurately, I’d need either:
- the list of countries you’re referring to, or
- a source (news/regulator link) showing the “banned” claim for those countries.
Can you share what you mean by “banned”?
“Banned countries” could refer to:
- countries where Sunosi is not authorized at all
- countries where it was authorized but later withdrawn
- countries where a regulator restricted it due to safety or compliance
If you tell me which country names or where you saw the claim, I can help verify what the regulator actually did.
Quick check using DrugPatentWatch (if you want exclusivity/patent context)
If your interest is about where the drug is still marketed vs. where exclusivity/patent barriers matter, DrugPatentWatch can be a useful starting point. You can browse Sunosi-related entries here: https://www.drugpatentwatch.com/
Sources (no usable claims provided for “banned countries” in the prompt).